BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14967131)

  • 1. [Dolichocolon as unwanted effect of treatment with the anti-depressant mirtazapine].
    Alda Díez M; Espuelas Monge M; García-Campayo J
    Aten Primaria; 2004 Feb; 33(2):106-7. PubMed ID: 14967131
    [No Abstract]   [Full Text] [Related]  

  • 2. Irritable bowel syndrome and mirtazapine.
    Thomas SG
    Am J Psychiatry; 2000 Aug; 157(8):1341-2. PubMed ID: 10910804
    [No Abstract]   [Full Text] [Related]  

  • 3. Mirtazapine-associated hyponatremia presenting as delirium.
    Ghosh A; Hegde A; Grover S
    Indian J Pharmacol; 2014; 46(4):448-9. PubMed ID: 25097290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-lethal mirtazapine overdose with rhabdomyolysis.
    Kuliwaba A
    Aust N Z J Psychiatry; 2005 Apr; 39(4):312-3. PubMed ID: 15777372
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressants and unresponsive episodes in the elderly.
    McGuinness J; Delicata M
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22805736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-onset mirtazapine-related leukopenia and rechallenge.
    Dholakia R; Schleifer SJ; Ahmad YJ; Narang IS
    J Clin Psychopharmacol; 2010 Dec; 30(6):758. PubMed ID: 21057250
    [No Abstract]   [Full Text] [Related]  

  • 7. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated episodes of neutropenia triggered by mirtazapine.
    Civalier KA; Krahn LE; Agrwal N
    Psychosomatics; 2009; 50(3):299-300. PubMed ID: 19567774
    [No Abstract]   [Full Text] [Related]  

  • 9. Mirtazapine use in two pregnant women: is it safe?
    Kesim M; Yaris F; Kadioglu M; Yaris E; Kalyoncu NI; Ulku C
    Teratology; 2002 Nov; 66(5):204. PubMed ID: 12397626
    [No Abstract]   [Full Text] [Related]  

  • 10. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
    Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
    J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report.
    Walder A; Baumann P
    Pharmacopsychiatry; 2009 Mar; 42(2):79-81. PubMed ID: 19308886
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin syndrome and atypical antipsychotics.
    Duggal HS; Fetchko J
    Am J Psychiatry; 2002 Apr; 159(4):672-3. PubMed ID: 11925312
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of efficacy and tolerability of mirtazapine treatment of patients with depression].
    Beszłej A; Grzesiak M
    Psychiatr Pol; 2002; 36(6 Suppl):115-23. PubMed ID: 12647430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated angioedema following administration of venlafaxine and mirtazapine.
    Lin CE; Chen CL
    Gen Hosp Psychiatry; 2010; 32(3):341.e1-2. PubMed ID: 20430242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine: unable to induce serotonin toxicity?
    Gillman PK
    Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
    Isbister GK; Whyte IM
    Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
    [No Abstract]   [Full Text] [Related]  

  • 17. Mirtazapine overdose with benign outcome.
    Raja M; Azzoni A
    Eur Psychiatry; 2002 Apr; 17(2):107. PubMed ID: 11973120
    [No Abstract]   [Full Text] [Related]  

  • 18. Mirtazapine and hyperpigmentation.
    Mendhekar D; Inamdar A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):688-9. PubMed ID: 19404867
    [No Abstract]   [Full Text] [Related]  

  • 19. Mirtazapine-induced akathisia.
    Girishchandra BG; Johnson L; Cresp RM; Orr KG
    Med J Aust; 2002 Mar; 176(5):242. PubMed ID: 11999246
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurologic oral manifestations caused by a new formulation of mirtazapine.
    Kling A; Dahlqvist R; Johansson S; Bäckström M; Mjörndal T
    Neurology; 2005 Jul; 65(2):333-4. PubMed ID: 16043818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.